[Study on the effect of COX-2's selective inhibitor on human colorectal adenoma cells proliferation]

C Qiu1, Q Ouyang

  • 1Department of Internal Medicine. First Hospital, West China University of Medical Sciences, Chengdu 610041, China.

Zhonghua Nei Ke Za Zhi
|January 19, 2002
PubMed
Abstract

Insights

The selective cyclooxygenase-2 (COX-2) inhibitor NS-398 effectively reduced human colorectal adenoma cell growth. Overexpression of COX-2 is an early event in colorectal cancer development.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Context:

  • Colorectal adenomas are precancerous lesions.
  • Cyclooxygenase-2 (COX-2) is implicated in tumor development.
  • Selective COX-2 inhibitors are potential therapeutic agents.

Purpose:

  • To investigate the mechanism of action of the selective COX-2 inhibitor NS-398 in human colorectal adenoma development.
  • To assess the effect of NS-398 on colorectal adenoma cell proliferation.
  • To examine COX-2 protein expression in colorectal tumors.

Summary:

  • Human colorectal adenoma cells were successfully cultured and treated with NS-398.
  • NS-398 demonstrated dose- and time-dependent inhibition of cell proliferation.
  • COX-2 was found to be overexpressed in colorectal adenomas and cancers compared to normal mucosa.

Impact:

  • Improved culture conditions for human colorectal adenoma cells.
  • Demonstrated NS-398's inhibitory effect on colorectal adenoma cell growth.
  • Established early overexpression of COX-2 in colorectal carcinogenesis, contributing to tumor formation.